REFRESH
ABBVIE CORPORATION
Quick answers
Is there a shortage of REFRESH in Canada?
No. There is no current shortage of REFRESH 1.4% reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
LIQUIFILM TEARS
ALLERGAN INC
R.O.-DRY EYES 1.4%
RICHMOND PHARMACEUTICALS INC.
Other Products
TEARS PLUS
ABBVIE CORPORATION
PMS-ARTIFICIAL TEARS DPS 1.4%
PHARMASCIENCE INC
OPTILUBE PVA LIQ 1.4%
PHARMA STULLN INC.
ARTIFICIAL TEARS
IVAX PHARMACEUTICALS INCORPORATED
DIN
02138670
Strength
1.4%
Dosage Form
Drops
Route
Ophthalmic
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from ABBVIE CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
35MG · DIN 02246896
150MG · DIN 02316838
35MG · DIN 02370417
0.5% · DIN 01968300
0.4% · DIN 02248722
0.45% · DIN 02369362
0.2% · DIN 02236876
0.15% · DIN 02248151
10MG · DIN 02443910
50UNIT · DIN 02531577
100UNIT · DIN 01981501
200UNIT · DIN 02531585